These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

117 related articles for article (PubMed ID: 39072556)

  • 1. Hexane insoluble fraction from purple rice extract improves steatohepatitis and fibrosis
    Naiki-Ito A; Yeewa R; Xiaochen K; Taychaworaditsakul W; Naiki T; Kato H; Nagayasu Y; Chewonarin T; Takahashi S
    Food Funct; 2024 Aug; 15(16):8562-8571. PubMed ID: 39072556
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A novel model of non-alcoholic steatohepatitis with fibrosis and carcinogenesis in connexin 32 dominant-negative transgenic rats.
    Naiki-Ito A; Kato H; Naiki T; Yeewa R; Aoyama Y; Nagayasu Y; Suzuki S; Inaguma S; Takahashi S
    Arch Toxicol; 2020 Dec; 94(12):4085-4097. PubMed ID: 32833043
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Lactoferrin Prevents Hepatic Injury and Fibrosis via the Inhibition of NF-κB Signaling in a Rat Non-Alcoholic Steatohepatitis Model.
    Aoyama Y; Naiki-Ito A; Xiaochen K; Komura M; Kato H; Nagayasu Y; Inaguma S; Tsuda H; Tomita M; Matsuo Y; Takiguchi S; Takahashi S
    Nutrients; 2021 Dec; 14(1):. PubMed ID: 35010924
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A network pharmacology approach: Inhibition of the NF-κB signaling pathway contributes to the NASH preventative effect of an Oroxylum indicum seed extract in oleic acid-stimulated HepG2 cells and high-fat diet-fed rats.
    Sun W; Liu P; Yang B; Wang M; Wang T; Sun W; Wang X; Zheng W; Song X; Li J
    Phytomedicine; 2021 Jul; 88():153498. PubMed ID: 33640247
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Empagliflozin ameliorates liver fibrosis in NASH rat model via targeting hepatic NF-κB/SOX9/OPN signaling and osteocalcin level.
    Elseweidy MM; Ali AE; Hassanin SM; Mahmoud YK
    Naunyn Schmiedebergs Arch Pharmacol; 2024 May; 397(5):3449-3459. PubMed ID: 37962587
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Total aralosides of aralia elata (Miq) seem (TASAES) ameliorate nonalcoholic steatohepatitis by modulating IRE1α-mediated JNK and NF-κB pathways in ApoE-/- mice.
    Luo Y; Dong X; Yu Y; Sun G; Sun X
    J Ethnopharmacol; 2015 Apr; 163():241-50. PubMed ID: 25655997
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Connexin 32 and luteolin play protective roles in non-alcoholic steatohepatitis development and its related hepatocarcinogenesis in rats.
    Sagawa H; Naiki-Ito A; Kato H; Naiki T; Yamashita Y; Suzuki S; Sato S; Shiomi K; Kato A; Kuno T; Matsuo Y; Kimura M; Takeyama H; Takahashi S
    Carcinogenesis; 2015 Dec; 36(12):1539-49. PubMed ID: 26494227
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [The roles of gap junctional intercellular communication in non-alcoholic steatohepatitis (NASH) and liver fibrosis].
    Naiki-Ito A
    Nihon Yakurigaku Zasshi; 2021; 156(3):152-156. PubMed ID: 33952843
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Long-term subcutaneous injection of lipopolysaccharides and high-fat diet induced non-alcoholic fatty liver disease through IKKε/ NF-κB signaling.
    He Q; Zeng J; Yao K; Wang W; Wu Q; Tang R; Xia X; Zou X
    Biochem Biophys Res Commun; 2020 Nov; 532(3):362-369. PubMed ID: 32883523
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Hepatocyte nuclear receptor SHP suppresses inflammation and fibrosis in a mouse model of nonalcoholic steatohepatitis.
    Zou A; Magee N; Deng F; Lehn S; Zhong C; Zhang Y
    J Biol Chem; 2018 Jun; 293(22):8656-8671. PubMed ID: 29666185
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Hepatic Mitochondrial SAB Deletion or Knockdown Alleviates Diet-Induced Metabolic Syndrome, Steatohepatitis, and Hepatic Fibrosis.
    Win S; Min RWM; Zhang J; Kanel G; Wanken B; Chen Y; Li M; Wang Y; Suzuki A; Aung FWM; Murray SF; Aghajan M; Than TA; Kaplowitz N
    Hepatology; 2021 Dec; 74(6):3127-3145. PubMed ID: 34331779
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Hypoxia-inducible factor-2 promotes liver fibrosis in non-alcoholic steatohepatitis liver disease via the NF-κB signalling pathway.
    Cai H; Bai Z; Ge RL
    Biochem Biophys Res Commun; 2021 Feb; 540():67-74. PubMed ID: 33450482
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Corosolic acid ameliorates non-alcoholic steatohepatitis induced by high-fat diet and carbon tetrachloride by regulating TGF-β1/Smad2, NF-κB, and AMPK signaling pathways.
    Liu G; Cui Z; Gao X; Liu H; Wang L; Gong J; Wang A; Zhang J; Ma Q; Huang Y; Piao G; Yuan H
    Phytother Res; 2021 Sep; 35(9):5214-5226. PubMed ID: 34213784
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Anti-inflammatory effect of genistein on non-alcoholic steatohepatitis rats induced by high fat diet and its potential mechanisms.
    Ji G; Yang Q; Hao J; Guo L; Chen X; Hu J; Leng L; Jiang Z
    Int Immunopharmacol; 2011 Jun; 11(6):762-8. PubMed ID: 21320636
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Fibrinogen-like protein 2 aggravates nonalcoholic steatohepatitis via interaction with TLR4, eliciting inflammation in macrophages and inducing hepatic lipid metabolism disorder.
    Hu J; Wang H; Li X; Liu Y; Mi Y; Kong H; Xi D; Yan W; Luo X; Ning Q; Wang X
    Theranostics; 2020; 10(21):9702-9720. PubMed ID: 32863955
    [No Abstract]   [Full Text] [Related]  

  • 16. Biochemical and histological characterisation of an experimental rodent model of non-alcoholic steatohepatitis - Effects of a peroxisome proliferator-activated receptor gamma (PPAR-γ) agonist and a glucagon-like peptide-1 analogue.
    Daniels SJ; Leeming DJ; Detlefsen S; Bruun MF; Hjuler ST; Henriksen K; Hein P; Karsdal MA; Brockbank S; Cruwys S
    Biomed Pharmacother; 2019 Mar; 111():926-933. PubMed ID: 30841472
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Chinese herbal medicine mixture 919 syrup alleviates nonalcoholic fatty liver disease in rats by inhibiting the NF-κB pathway.
    Chen M; Xing J; Pan D; Peng X; Gao P
    Biomed Pharmacother; 2020 Aug; 128():110286. PubMed ID: 32521450
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Pyrvinium pamoate attenuates non-alcoholic steatohepatitis: Insight on hedgehog/Gli and Wnt/β-catenin signaling crosstalk.
    El-Derany MO; El-Demerdash E
    Biochem Pharmacol; 2020 Jul; 177():113942. PubMed ID: 32240652
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Silymarin suppresses hepatic stellate cell activation in a dietary rat model of non-alcoholic steatohepatitis: analysis of isolated hepatic stellate cells.
    Kim M; Yang SG; Kim JM; Lee JW; Kim YS; Lee JI
    Int J Mol Med; 2012 Sep; 30(3):473-9. PubMed ID: 22710359
    [TBL] [Abstract][Full Text] [Related]  

  • 20. MicroRNA-378 promotes hepatic inflammation and fibrosis via modulation of the NF-κB-TNFα pathway.
    Zhang T; Hu J; Wang X; Zhao X; Li Z; Niu J; Steer CJ; Zheng G; Song G
    J Hepatol; 2019 Jan; 70(1):87-96. PubMed ID: 30218679
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.